Mysthera Therapeutics
Basel
About Mysthera Therapeutics
Mysthera Therapeutics is a pharmaceutical company Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in multiple lineages associated with complex disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Seed (Aug 2023)
- Website: mystheratx.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/mysthera-therapeutics-80989 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.